Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide
- 1 October 1990
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 82 (3) , 213-217
- https://doi.org/10.1007/bf01272764
Abstract
Studies were carried out in the rat in order to investigate whether cholinergic mechanisms may be involved in vasopressin (VP) release induced by metoclopramide (MCP). The intravenous injection of MCP induced doserelated increases in plasma VP levels in water-loaded rats. These effects were prevented by atropine sulphate, but not by pirenzepine hydrochloride indicating that activation of cholinergic receptors of M-2 type was possibly required for the biologic response.Keywords
This publication has 8 references indexed in Scilit:
- Alterations in vasopressin regulation in Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Metoclopramide Increases Vasopressin SecretionJournal of Clinical Endocrinology & Metabolism, 1986
- Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the ratEuropean Journal of Pharmacology, 1985
- Peripheral receptor populations involved in the regulation of gastrointestinal motility and the pharmacological actions of metoclopramide-like drugsLife Sciences, 1985
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- Central nervous system mediators of vasopressin releasePhysiological Reviews, 1983
- MetoclopramideNew England Journal of Medicine, 1981
- Radioimmunoassay of Arginine Vasopressin in Human PlasmaJournal of Clinical Endocrinology & Metabolism, 1973